Live feed
Filing
SC 13G
SC 13G0000902219-15-000549·ALPINE IMMUNE SCIENCES, INC.
Schedule 13G ownership disclosure
NIVALIS THERAPEUTICS INC
Security class unavailable · CUSIP: 65481J109
Event date: 2015-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,646,700
- Percent of class
- 11.2600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-15-000549
- Form type
- SC 13G
- Filer
- ALPINE IMMUNE SCIENCES, INC.
- CIK
- CIK 1626199
- Filed
- Jul 10, 2015
- Reporting period
- Jun 30, 2015
- Description
- Schedule 13G beneficial ownership